Clinical Trial Update: Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating capecitabine plus docetaxel in patients with recurrent or progressive metastatic pancreatic cancer has completed enrollment an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: University of Miami | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-05-13